Showing results (2071-2080 of 2,113) with videos related to

Sort By:
Pageof 212
Journal of Clinical Epidemiology|April 30, 2013
The GRADE approach is reproducible in assessing the quality of evidence of quantitative evidence synthesesReem A Mustafa, Nancy Santesso, Jan Brozek, et al.
Genome Biology|July 7, 2021
Integration of metabolomics, genomics, and immune phenotypes reveals the causal roles of metabolites in diseaseXiaojing Chu, Martin Jaeger, Joep Beumer, et al.
Medrxiv : the Preprint Server for Health Sciences|June 10, 2025
HLA-B Alleles with Shared Peptide Binding Specificities Define Global Risk of Cotrimoxazole-induced SCARYueran Li, Andrew Gibson, Hajirah N Saeed, et al.
The Journal of Allergy and Clinical Immunology. in Practice|August 10, 2025
HLA-B Alleles With Shared Peptide Binding Specificities Define Global Risk of Co-trimoxazole-Induced Severe Cutaneous Adverse Drug ReactionsYueran Li, Andrew Gibson, Hajirah N Saeed, et al.
BMJ Open|March 27, 2023
Biomarker-guided intervention to prevent acute kidney injury after major surgery (BigpAK-2 trial): study protocol for an international, prospective, randomised controlled multicentre trialThilo von Groote, Melanie Meersch, Stefano Romagnoli, et al.
Pediatrics|June 15, 2025
Pediatric Fellows and Their Ability to Meet Minimum Supervision Levels at GraduationPnina G Weiss, Alan Schwartz, Donald L Boyer, et al.
Pediatrics|March 16, 2025
Many Pediatric Subspecialty Fellows Are Not Ready to Graduate From Fellowship in 2 YearsSarah Pitts, Alan Schwartz, Melissa L Langhan, et al.
Human Molecular Genetics|September 6, 2012
Mutations in FKBP10, which result in Bruck syndrome and recessive forms of osteogenesis imperfecta, inhibit the hydroxylation of telopeptide lysines in bone collagenUlrike Schwarze, Tim Cundy, Shawna M Pyott, et al.
Pediatrics|May 17, 2024
Implementing Entrustable Professional Activities in Pediatric Fellowships: Facilitating the ProcessMelissa L Langhan, Donald L Boyer, Deborah Hsu, et al.
Cancer Research|July 2, 2026
CDK2 Inhibition Exerts RB-Independent Antitumor Activity in CDK4/6 Inhibitor-Resistant HR+/HER2- Breast CancerDejan Juric, Kazi N Islam, Ioanna-Maria Gkotinakou, et al.
Pageof 212